Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1525 of 2529 entries
View as:

Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride

Phase: N/A Priority: Normal
NCT ID: NCT02007278 Org: User:
Start: 01/03/14 End: 02/22/16 Due: 02/22/17

Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02697734 Org: User:
Start: 10/03/16 End: 12/31/20 Due: 12/31/21

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01544491 Org: User:
Start: 08/17/12 End: 09/24/18 Due: 09/24/19

Real-World Usage of Asciminib Among Patients With Chronic Myeloid Leukemia in Chronic Phase in the United States Using a Large Claims Database

Phase: N/A Priority: Normal
NCT ID: NCT06148493 Org: User:
Start: 09/20/22 End: 12/15/22 Due: 12/15/23

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Phase: N/A Priority: Normal
NCT ID: NCT00631163 Org: User:
Start: 10/31/07 End: 02/29/12 Due: 02/28/13

Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT02855164 Org: User:
Start: 08/01/16 End: 04/06/20 Due: 04/06/21

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT03257995 Org: User:
Start: 09/05/17 End: 01/18/18 Due: 01/18/19

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05798117 Org: User:
Start: 02/28/23 End: 09/09/26 Due: 09/09/27

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT04659863 Org: User:
Start: 02/16/21 End: 11/18/24 Due: 11/18/25

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT03940352 Org: User:
Start: 06/24/19 End: 08/20/24 Due: 08/20/25

Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

Phase: N/A Priority: Normal
NCT ID: NCT01056822 Org: User:
Start: 05/31/10 End: 04/30/13 Due: 04/30/14

A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy

Phase: N/A Priority: Normal
NCT ID: NCT05592990 Org: User:
Start: 06/14/23 End: 12/03/25 Due: 12/03/26

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT02435212 Org: User:
Start: 10/21/15 End: 01/15/24 Due: 01/15/25

Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks

Phase: N/A Priority: Normal
NCT ID: NCT02232061 Org: User:
Start: 09/29/14 End: 01/24/20 Due: 01/24/21

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01498887 Org: User:
Start: 12/24/11 End: 12/26/15 Due: 12/26/16

Secukinumab Global MAP Cohort for Adult Patients With Hidradenitis Suppurativa (HS)

Phase: N/A Priority: Normal
NCT ID: NCT05583604 Org: User:
Start: - End: - Due: -

Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

Phase: N/A Priority: Normal
NCT ID: NCT05764265 Org: User:
Start: 03/27/23 End: 05/14/24 Due: 05/14/25

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02083354 Org: User:
Start: 03/18/14 End: 04/19/21 Due: 04/19/22

Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)

Phase: N/A Priority: Normal
NCT ID: NCT01614886 Org: User:
Start: 07/31/12 End: 05/31/14 Due: 05/31/15

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01129336 Org: User:
Start: 06/30/10 End: 08/31/12 Due: 08/31/13

A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in Korea

Phase: N/A Priority: Normal
NCT ID: NCT04946305 Org: User:
Start: 05/10/22 End: 07/08/24 Due: 07/08/25

24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00555789 Org: User:
Start: 10/31/07 End: 03/31/08 Due: 03/31/09

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00247663 Org: User:
Start: 12/31/99 End: - Due: -

Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03671330 Org: User:
Start: 08/29/18 End: 05/09/25 Due: 05/09/26

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05552469 Org: User:
Start: 05/08/23 End: 02/01/27 Due: 02/01/28